hiv/aids and substance use disorders olivera j. bogunovic, m.d. state university of new york at...

34
HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Upload: judith-jenkins

Post on 21-Dec-2015

216 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

HIV/AIDS and Substance Use Disorders

Olivera J. Bogunovic, M.D.State University of New York at Buffalo

Alcohol Medical Scholars Program

Page 2: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 2

Lecture Overview

HIV/AIDS

Substance use disorders

Connection between HIV and substance use disorders

Implications for patient care

Page 3: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 3

Patient: John

• 40-year old white male presents to ER with:– Diarrhea >1 month, thrush, weight loss

• History: – Intravenous heroin user– Failed inpatient rehabilitation

• Labs:– CD4 <400

Page 4: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 4

HIV - Human Immunodeficiency Virus

• RNA virus

• Principally infected cell: CD4 T cell

• Progressive loss of cell

Page 5: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 5

Epidemiology

• >39 million HIV+

• ~40,000 persons infected/year (CDC)

• High-risk populations:– Injection drug users: 26% of all infections

– Homosexual males: 60% of all infections

Page 6: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 6

HIV Transmission Categories

Centers for Disease Control, 2005

Males Females

Male-Male Sex 60% -

Hetero Sex 13% 71%

Injection Drug Use 26% 27%

Other 1% 2%

Page 7: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 7

Other HIV Transmission Categories

• Maternal transmission during childbirth

• Health workers

• Blood transfusions

• Tattoos

Page 8: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 8

Course of HIV Infection

• Six stages of infection:1. Initial 2. Latency 3. Lymphadenopathy4. Early symptomatic infection5. AIDS6. End stage

Page 9: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 9

Treatment of HIV/AIDS

• Prevention of HIV transmission

• Antiretroviral treatment: immune function viral replication

• Treatment of opportunistic infections

Page 10: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 10

Antiretroviral Medications

• Nucleoside and nucleotide analogs (zidovudine)

• Protease inhibitors (saquinavir)

• Non-nucleoside transcriptase (nevirapine)

Page 11: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 11

Lecture Overview

HIV/AIDS

Substance use disorders (SUD)

Connection between HIV and substance use disorders

Implications for patient care

Page 12: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 12

Relevant Drugs to HIV/AIDS

• Opioids

• Stimulants

–Amphetamine

–Cocaine

• Alcohol

Page 13: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 13

Substance Use Disorders

• Misuse = use to get high

• Abuse = dysfunction in 1+ life areas

• Dependence = 3+ of 7 criteria–Physical dependence

–Compulsive use/loss of control

Page 14: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 14

Lifetime Prevalence

• Opioids– Abuse/dependence of heroin <1%

• Stimulants– Amphetamine

• Abuse/dependence < 2%

– Cocaine• Abuse/dependence 2%

• Alcohol• Abuse or dependence 10-15% men, 8-10% women

Page 15: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 15

Routes of Administration

• Injection: highest risk of infection

• Intranasal

• Smoking

• Oral

Page 16: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 16

Treatment

•Individual and group psychotherapy

•Pharmacotherapy

•Self help groups

Page 17: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 17

Lecture Overview

HIV/AIDS

Substance use disorders

Connection between HIV and substance use disorders

Implications for patient care

Page 18: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 18

Prevalence

• High prevalence of HIV in patients with SUD– 35% of cocaine users

– 22% of opioid users

• High prevalence of SUD in HIV+ patients– 25% alcohol dependent

– 25% use illicit opioids

– 33% use cocaine

Page 19: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 19

Drug Use and HIV Transmission

• Highest risk with intravenous use

• Increased risk with intranasal use

• More sexual partners, unsafe sex

• Associated with alcohol use

Page 20: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 20

Opioids Affect HIV Course

• Cause immunosuppression

• Induce apoptosis

viral replication

• Co-infection of HIV and other pathogens

Page 21: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 21

Stimulants Affect HIV Course

• Cocaine– Causes immunosuppression of T-cells viral replication brain cells infected neurotoxicity

• Amphetamine– Similar effect to cocaine

– Research beginning to accumulate

Page 22: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 22

Alcohol Affects HIV Course

immune response to HIV infection

viral replication

• Promotes progression of illness

permeability of blood brain barrier to infectious agents

Page 23: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 23

Drugs/Alcohol Affect HIV

Alcohol

Apoptosis

CNS Barrier

↑ Viral Replication

Neurotoxicity

↓ Immune System

Opioids

Stimulants

Page 24: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 24

Opioids Affect Antiretrovirals

• Opioids high risk behavior / noncompliance

• Drug-drug interactions– Methadone levels with meds

– Methadone dose adjustment needed blood levels of meds

Page 25: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 25

Stimulants Affect Antiretrovirals

• Cocaine risk behaviors

–Resistance to antiretrovirals in 30% due to noncompliance

• Amphetamine –↑ risk behavior

Page 26: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 26

Alcohol Affects Antiretrovirals

risk behavior and noncompliance

viral replication

response to antiretroviral medications

• Impairs pharmacokinetics and pharmacodynamics of antiretrovirals

Page 27: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 27

Drugs/Alcohol Affect Meds

Alcohol

Resistance

Drug Interactions

Noncompliance

Opioids

Stimulants

Page 28: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 28

Substance Use and Compliance with Medications

• Inconsistent outpatient care

• Noncompliance with medication regimen– 44% users vs. 22% non-users

• Poor social support

• Methadone maintenance programs better adherence to treatment

Page 29: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 29

Psychiatric Disorders, HIV & SUD

• Drugs/alcohol cause & exacerbate

psychiatric symptoms

–Psychiatric symptoms more common

–HIV+ more sensitive to illicit drugs

Page 30: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 30

Lecture Overview

HIV/AIDS

Substance use disorders

Connection between HIV and substance use disorders

Implications for patient care

Page 31: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 31

Treatment Guidelines

• Maximizing care for HIV and SUD

–Medical treatment

• Asymptomatic infection: antiretroviral meds

• Symptomatic infection: treat opportunistic infection

Page 32: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 32

Treatment Guidelines

• SUD treatment–Reduce HIV risk behavior

–Harm reduction model

• Methadone maintenance

• Syringe exchange programs

–Mental health treatment

Page 33: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 33

What About John

• HIV: treat with antiretrovirals

• SUD treatment:

– Consider methadone maintenance

– Cognitive-behavioral therapy

– Self-help groups

• Mental health treatment if indicated

Page 34: HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program

Copyright Alcohol Medical Scholars Program 34

Summary

HIV/AIDS

Substance use disorders

Connection between HIV and substance use disorders

Implications for patient care